Briefing room. Surgeon genrich ardeeral richar joins me. But first the numbers. The United States is now fast approaching 1 million confirmed coronavirus cases. More than 54,000 americans have died. And at the current rate, the pandemics death toll will surpass that of the vietnam war this week. More than 26 million americans have filed for unemployment over the past five weeks. That means one in six American Workers have lost their jobs since this crisis began. And its against that backdrop that some states are now taking steps to open back up. In georgia, businesses like gyms, bowling alleys, nail salons and barber shops reopened on friday. And tomorrow restaurants and movie theaters will follow suit. In tennessee residents of some parts of the state will be able to sit down for meals in restaurants tomorrow as well. And in colorado, the states democratic governor jared polis is defending his plan to start a phased reopening this week. And its at this Inflection Point that the presid
Vertex Pharma (VRTX) Reports New Data from VX-880 Phase 1/2 Trial streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ (OTC-CELZ) Creative Medical Technology Holdings Inc. announced today proof of concept data demonstrating the ability of its next generation.
iTolerance, Inc., a Company Pioneering Regenerative Medicine Without Immunosuppression, Announces Leadership Team
Lead product candidate, ITOL-101, for the treatment of Type 1 Diabetes entering IND-enabling studies
Anthony Japour, M.D., a seasonedbiotech and pharmaceutical executive with over 30 years of experience, appointed as Chief Executive Officer
Camillo Ricordi, M.D., one of the world s leading scientists in diabetes cure-focused research, cell transplantation and regenerative medicine, appointed as Chief Scientist
SAN MATEO, CA / ACCESSWIRE / June 9, 2021 / iTolerance, Inc
. ( iTolerance or the Company ), a biotechnology company focused on the development of innovative regenerative medicines, today announced the formation of its Executive Leadership Team with the hiring of Anthony Japour, M.D. as Chief Executive Officer and Camillo Ricordi, M.D. as Chief Scientist.